

Other version: http://journals.lww.com/journalppo/Abstract/2005/03000/Preoperative_Concomitant_Hyperfractionated.8.aspx
![]() |
Preoperative concomitant hyperfractionated radiotherapy and gemcitabine for locally advanced rectal cancers: a phase I-II trial |
|
Authors | ||
Published in | The cancer journal. 2005, vol. 11, no. 2, p. 133-9 | |
Abstract | The purpose of this study was to determine the maximum tolerated dose of gemcitabine when it was administered concomitantly with hyperfractionated radiotherapy before surgery in patients with locally advanced rectal cancers and to investigate the midterm efficacy of such a regimen. | |
Keywords | Adult — Aged — Deoxycytidine/administration & dosage/adverse effects/analogs & derivatives/therapeutic use — Dose Fractionation — Female — Humans — Male — Middle Aged — Neoplasm Staging — Preoperative Care — Radiation-Sensitizing Agents/administration & dosage/adverse effects/therapeutic use — Radiotherapy, Adjuvant — Radiotherapy, Conformal — Rectal Neoplasms/drug therapy/pathology/radiotherapy — Survival Analysis — Time Factors — Treatment Outcome | |
Identifiers | PMID: 15969988 | |
Full text |
![]() ![]() Other version: http://journals.lww.com/journalppo/Abstract/2005/03000/Preoperative_Concomitant_Hyperfractionated.8.aspx |
|
Structures | ||
Research groups | Chirurgie viscérale (104) Chirurgie viscérale (HUG) Groupe Roth Arnaud (oncologie) (285) | |
Citation (ISO format) | ALLAL, Abdelkarim Said et al. Preoperative concomitant hyperfractionated radiotherapy and gemcitabine for locally advanced rectal cancers: a phase I-II trial. In: The cancer journal, 2005, vol. 11, n° 2, p. 133-9. doi: 10.1097/00130404-200503000-00008 https://archive-ouverte.unige.ch/unige:39101 |